454 related articles for article (PubMed ID: 15368290)
1. Transgene-mediated hyper-expression of IL-5 inhibits autoimmune disease but increases the risk of B cell chronic lymphocytic leukemia in a model of murine lupus.
Wen X; Zhang D; Kikuchi Y; Jiang Y; Nakamura K; Xiu Y; Tsurui H; Takahashi K; Abe M; Ohtsuji M; Nishimura H; Takatsu K; Shirai T; Hirose S
Eur J Immunol; 2004 Oct; 34(10):2740-9. PubMed ID: 15368290
[TBL] [Abstract][Full Text] [Related]
2. IL-4Ralpha polymorphism in regulation of IL-4 synthesis by T cells: implication in susceptibility to a subset of murine lupus.
Shiroiwa W; Tsukamoto K; Ohtsuji M; Lin Q; Ida A; Kodera S; Ohtsuji N; Nakamura K; Tsurui H; Kinoshita K; Nishimura H; Shirai T; Hirose S
Int Immunol; 2007 Feb; 19(2):175-83. PubMed ID: 17189592
[TBL] [Abstract][Full Text] [Related]
3. Defects in the regulation of anti-DNA antibody production in aged lupus-prone (NZB x NZW)F1 mice: analysis of T-cell lymphokine synthesis.
Sato MN; Minoprio P; Avrameas S; Ternynck T
Immunology; 1995 May; 85(1):26-32. PubMed ID: 7635519
[TBL] [Abstract][Full Text] [Related]
4. Polyclonal B cell activation arises from different mechanisms in lupus-prone (NZB x NZW)F1 and MRL/MpJ-lpr/lpr mice.
Merino R; Iwamoto M; Fossati L; Izui S
J Immunol; 1993 Dec; 151(11):6509-16. PubMed ID: 7902378
[TBL] [Abstract][Full Text] [Related]
5. Responses of B cells from autoimmune mice to IL-5.
Umland SP; Go NF; Cupp JE; Howard M
J Immunol; 1989 Mar; 142(5):1528-35. PubMed ID: 2783944
[TBL] [Abstract][Full Text] [Related]
6. CD40-mediated stimulation of B1 and B2 cells: implication in autoantibody production in murine lupus.
Kaneko Y; Hirose S; Abe M; Yagita H; Okumura K; Shirai T
Eur J Immunol; 1996 Dec; 26(12):3061-5. PubMed ID: 8977305
[TBL] [Abstract][Full Text] [Related]
7. T cell cytokine imbalance towards production of IFN-gamma and IL-10 in NZB/W F1 lupus-prone mice is associated with autoantibody levels and nephritis.
Enghard P; Langnickel D; Riemekasten G
Scand J Rheumatol; 2006; 35(3):209-16. PubMed ID: 16766368
[TBL] [Abstract][Full Text] [Related]
8. B cells are anergic in transgenic mice that express IgM anti-DNA antibodies.
Tsao BP; Chow A; Cheroutre H; Song YW; McGrath ME; Kronenberg M
Eur J Immunol; 1993 Sep; 23(9):2332-9. PubMed ID: 8370409
[TBL] [Abstract][Full Text] [Related]
9. Resting B cells from autoimmune lupus-prone New Zealand Black and (New Zealand Black x New Zealand White)F1 mice are hyper-responsive to T cell-derived stimuli.
Jongstra-Bilen J; Vukusic B; Boras K; Wither JE
J Immunol; 1997 Dec; 159(12):5810-20. PubMed ID: 9550377
[TBL] [Abstract][Full Text] [Related]
10. Further evidence against random polyclonal antibody formation in mice with lupus-like graft-vs-host disease.
van Rappard-Van der Veen FM; Kiesel U; Poels L; Schuler W; Melief CJ; Landegent J; Gleichmann E
J Immunol; 1984 Apr; 132(4):1814-20. PubMed ID: 6321591
[TBL] [Abstract][Full Text] [Related]
11. Treatment with high doses of anti-IgM prevents, but with lower doses accelerates autoimmune disease in (NZW x BXSB)F1 hybrid mice.
Cerny A; Starobinski M; Hügin AW; Sutter S; Zinkernagel RM; Izui S
J Immunol; 1987 Jun; 138(12):4222-8. PubMed ID: 3495583
[TBL] [Abstract][Full Text] [Related]
12. Protection against renal disease in (NZB x NZW)F(1) lupus-prone mice after somatic B cell gene vaccination with anti-DNA immunoglobulin consensus peptide.
Ferrera F; Hahn BH; Rizzi M; Anderson M; Fitzgerald J; Millo E; Indiveri F; Shi FD; Filaci G; La Cava A
Arthritis Rheum; 2007 Jun; 56(6):1945-53. PubMed ID: 17530718
[TBL] [Abstract][Full Text] [Related]
13. Mechanisms of T and B cell collaboration in the in vitro production of anti-DNA antibodies in the NZB/NZW F1 murine SLE model.
Ando DG; Sercarz EE; Hahn BH
J Immunol; 1987 May; 138(10):3185-90. PubMed ID: 2952711
[TBL] [Abstract][Full Text] [Related]
14. B cell apoptosis accelerates the onset of murine lupus.
Trébéden-Nègre H; Weill B; Fournier C; Batteux F
Eur J Immunol; 2003 Jun; 33(6):1603-12. PubMed ID: 12778478
[TBL] [Abstract][Full Text] [Related]
15. Treatment of lupus-prone NZB/NZW F1 mice with recombinant soluble Fc gamma receptor II (CD32).
Werwitzke S; Trick D; Sondermann P; Kamino K; Schlegelberger B; Kniesch K; Tiede A; Jacob U; Schmidt RE; Witte T
Ann Rheum Dis; 2008 Feb; 67(2):154-61. PubMed ID: 17557887
[TBL] [Abstract][Full Text] [Related]
16. Anti-interleukin-6 monoclonal antibody inhibits autoimmune responses in a murine model of systemic lupus erythematosus.
Liang B; Gardner DB; Griswold DE; Bugelski PJ; Song XY
Immunology; 2006 Nov; 119(3):296-305. PubMed ID: 17067309
[TBL] [Abstract][Full Text] [Related]
17. IL-13 has only a subset of IL-4-like activities on B chronic lymphocytic leukaemia cells.
Fluckiger AC; Brière F; Zurawski G; Bridon JM; Banchereau J
Immunology; 1994 Nov; 83(3):397-403. PubMed ID: 7530690
[TBL] [Abstract][Full Text] [Related]
18. B-cell anergy is maintained in anti-DNA transgenic NZB/NZW mice.
Kat I; Makdasi E; Fischel R; Eilat D
Int Immunol; 2010 Feb; 22(2):101-11. PubMed ID: 20038519
[TBL] [Abstract][Full Text] [Related]
19. Cross-reactivity of human lupus anti-DNA antibodies with alpha-actinin and nephritogenic potential.
Zhao Z; Weinstein E; Tuzova M; Davidson A; Mundel P; Marambio P; Putterman C
Arthritis Rheum; 2005 Feb; 52(2):522-30. PubMed ID: 15693007
[TBL] [Abstract][Full Text] [Related]
20. Effects of anti-CD154 treatment on B cells in murine systemic lupus erythematosus.
Wang X; Huang W; Schiffer LE; Mihara M; Akkerman A; Hiromatsu K; Davidson A
Arthritis Rheum; 2003 Feb; 48(2):495-506. PubMed ID: 12571860
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
